Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Saturday, May 4, 2024 | Back issues
Courthouse News Service Courthouse News Service

EpiPen Class Action

A federal court in Kansas ruled partially in favor of Mylan in a class action suit brought by EpiPen consumers. The court granted Mylan summary judgment on RICO claims and antitrust claims based on rebate agreements but claims based on a settlement agreement with generic drug manufacturer Teva in 2012 will continue to trial.

KANSAS CITY, Kan. — A federal court in Kansas ruled partially in favor of Mylan in a class action suit brought by EpiPen consumers. Mylan won summary judgment on claims that its rebate agreements violated federal anti-racketeering and antitrust law, but claims based on a 2012 settlement agreement with generic drug manufacturer Teva will continue to trial. 

Categories / Business, Consumers, Health

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...